Reading the whole genetic blueprint of a fetus long before birth could become a routine procedure thanks to a new blood test.
Scientists have developed a new system to rapidly determine which cancer drugs are likely to work best given a patient’s genetic markers.
Roche is continuing to battle better-established medicines made by its rivals, and none more so than with its latest immuno-oncology cocktail.
The World Anti-Doping Agency has considered obtaining Olympic athletes’ genetic code for years, and now that could soon be becoming a reality, thanks to the decreasing cost of sequencing.
Scientists have tweaked the DNA in human heart cells to correct mutations that cause a deadly disease, which if proved safe could eventually cure children of Duchenne Muscular Dystrophy (DMD).
Google’s DeepMind has potentially made the first significant application of Artificial Intelligence (A.I.) in healthcare, after developing AI to diagnose disease by analysing medical images.
After approving 46 novel drugs in addition to several biological license applications back in 2017, could this year be another big year for approvals?
A new animal study involving virally-delivered gene therapies has indicated that high treatment doses might not be as safe as previous human trials have suggested
During the Festival of Genomics London, global biotech company, Dante Labs announced the launch of its privately funded 10,000 European Genome Project.